NEW YORK (GenomeWeb News) – The US Food and Drug Administration has cleared Diagnostic Hybrids' respiratory viral identification kit for use in the US, the company said Tuesday.

Diagnostic Hybrids, which is based in Athens, Ohio, said that the FDA has cleared its D3 Fastpoint L-DFA RSV/MPV Identification kit.

The kit allows for the identification of respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) in less than 25 minutes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.